ME Therapeutics Holding (XCNQ:METX) Days Payable : 0.00 (As of Feb. 2024)

View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Days Payable?

ME Therapeutics Holding's average Accounts Payable for the three months ended in Feb. 2024 was C$0.04 Mil. ME Therapeutics Holding's Cost of Goods Sold for the three months ended in Feb. 2024 was C$0.00 Mil.

The historical rank and industry rank for ME Therapeutics Holding's Days Payable or its related term are showing as below:

XCNQ:METX's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 148.28
* Ranked among companies with meaningful Days Payable only.

ME Therapeutics Holding's Days Payable stayed the same from Dec. 2022 (0.00) to Feb. 2024 (0.00). stayed the same

ME Therapeutics Holding Days Payable Historical Data

The historical data trend for ME Therapeutics Holding's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Days Payable Chart

ME Therapeutics Holding Annual Data

Trend

Aug22

Aug23

Days Payable

ME Therapeutics Holding Quarterly Data
	Aug22	Dec22	May23	Aug23	Nov23	Feb24
Days Payable	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of ME Therapeutics Holding's Days Payable

For the Biotechnology subindustry, ME Therapeutics Holding's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ME Therapeutics Holding's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ME Therapeutics Holding's Days Payable distribution charts can be found below:

* The bar in red indicates where ME Therapeutics Holding's Days Payable falls into.

ME Therapeutics Holding Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

ME Therapeutics Holding's Days Payable for the fiscal year that ended in Aug. 2023 is calculated as

	Days Payable (A: Aug. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Aug. 2022 )	+	Accounts Payable (A: Aug. 2023 ))	/	count )	/	Cost of Goods Sold (A: Aug. 2023 )	*	Days in Period
=	( (0.025	+	0.107)	/	2 )	/	0	*	365
=	0.066					/	0	*	365
=	N/A

ME Therapeutics Holding's Days Payable for the quarter that ended in Feb. 2024 is calculated as:

	Days Payable (Q: Feb. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Nov. 2023 )	+	Accounts Payable (Q: Feb. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Feb. 2024 )	*	Days in Period
=	( (0.037	+	0)	/	1 )	/	0	*	365 / 4
=	0.037					/	0	*	365 / 4
=	N/A

ME Therapeutics Holding Days Payable Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

ME Therapeutics Holding (XCNQ:METX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

Q9T:Germany

Address

177 Robson Street, Vancouver, BC, CAN, V6B 0N3

Website

https://www.metherapeutics.com

ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines